Literature DB >> 22092154

Acute encephalopathy in children with Dravet syndrome.

Akihisa Okumura1, Mitsugu Uematsu, George Imataka, Manabu Tanaka, Tohru Okanishi, Tetsuo Kubota, Akira Sudo, Jun Tohyama, Megumi Tsuji, Iori Ohmori, Misako Naiki, Ayako Hiraiwa-Sofue, Hitoshi Sato, Shinji Saitoh, Toshiaki Shimizu.   

Abstract

PURPOSE: The occurrence of acute encephalopathy in children with Dravet syndrome has been reported sporadically. This study clarified the features of acute encephalopathy in children with Dravet syndrome.
METHODS: Through the mailing list of the Annual Zao Conference on Pediatric Neurology, we collected 15 patients with clinically diagnosed Dravet syndrome, who had acute encephalopathy, defined as a condition with decreased consciousness with or without other neurologic symptoms, such as seizures, lasting for >24 h in association with infectious symptoms. KEY
FINDINGS: There were seven boys and eight girls. A mutation of the SCN1A gene was present in nine (truncation in six and missense in three). The frequency of seizures during the 3 months before the onset of acute encephalopathy was monthly in seven children and none in three. The median age at the onset of acute encephalopathy was 44 months (range 8-184 months). All children had status epilepticus followed by coma as the initial manifestation. Two different distributions of brain lesions were observed on diffusion-weighted images during the acute phase: cerebral cortex-dominant lesions with or without deep gray matter involvement and subcortical-dominant lesions. Four children died; nine survived with severe sequelae, and two had moderate sequelae. SIGNIFICANCE: We must be aware that acute encephalopathy is an important complication in children with Dravet syndrome, and associated with fulminant clinical manifestations and a poor outcome. Wiley Periodicals, Inc.
© 2011 International League Against Epilepsy.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22092154     DOI: 10.1111/j.1528-1167.2011.03311.x

Source DB:  PubMed          Journal:  Epilepsia        ISSN: 0013-9580            Impact factor:   5.864


  9 in total

1.  Incidence of Dravet Syndrome in a US Population.

Authors:  Yvonne W Wu; Joseph Sullivan; Sharon S McDaniel; Miriam H Meisler; Eileen M Walsh; Sherian Xu Li; Michael W Kuzniewicz
Journal:  Pediatrics       Date:  2015-10-05       Impact factor: 7.124

Review 2.  Oxidative Stress, a Crossroad Between Rare Diseases and Neurodegeneration.

Authors:  Carmen Espinós; Máximo Ibo Galindo; María Adelaida García-Gimeno; José Santiago Ibáñez-Cabellos; Dolores Martínez-Rubio; José María Millán; Regina Rodrigo; Pascual Sanz; Marta Seco-Cervera; Teresa Sevilla; Andrea Tapia; Federico V Pallardó
Journal:  Antioxidants (Basel)       Date:  2020-04-15

3.  Acute encephalopathy in children with tuberous sclerosis complex.

Authors:  Shingo Numoto; Hirokazu Kurahashi; Atsushi Sato; Masaya Kubota; Takashi Shiihara; Tohru Okanishi; Ryuta Tanaka; Ichiro Kuki; Tetsuhiro Fukuyama; Mitsuru Kashiwagi; Mitsuru Ikeno; Kazuo Kubota; Manami Akasaka; Masakazu Mimaki; Akihisa Okumura
Journal:  Orphanet J Rare Dis       Date:  2021-01-06       Impact factor: 4.123

Review 4.  A Comprehensive Review of Pediatric Acute Encephalopathy.

Authors:  George Imataka; Shigeko Kuwashima; Shigemi Yoshihara
Journal:  J Clin Med       Date:  2022-10-07       Impact factor: 4.964

5.  De novo homozygous variant of the SCN1A gene in a patient with severe Dravet syndrome complicated by acute encephalopathy.

Authors:  Le Thi Khanh Van; Huynh Thi Dieu Hien; Huynh Thi Thuy Kieu; Nguyen Le Trung Hieu; Le Sy Vinh; Giang Hoa; Do Thi Thu Hang
Journal:  Neurogenetics       Date:  2021-03-05       Impact factor: 2.660

6.  Fenfluramine in the successful treatment of super-refractory status epilepticus in a patient with Dravet syndrome.

Authors:  David Millett; Suzanne Pach
Journal:  Epilepsy Behav Rep       Date:  2021-05-31

7.  Analysis of multiple B-value diffusion-weighted imaging in pediatric acute encephalopathy.

Authors:  Yasuhiko Tachibana; Noriko Aida; Tetsu Niwa; Kumiko Nozawa; Kouki Kusagiri; Kana Mori; Kazuo Endo; Takayuki Obata; Tomio Inoue
Journal:  PLoS One       Date:  2013-06-03       Impact factor: 3.240

8.  Vaccinations and Dravet Syndrome.

Authors:  Christian M Korff
Journal:  Pediatr Neurol Briefs       Date:  2015-11

9.  Can the combination of hyperthermia, seizures and ion channel dysfunction cause fatal post-ictal cerebral edema in patients with SCN1A mutations?

Authors:  Carina Büren; Marcel Alexander Kamp; Christopher Munoz-Bendix; Hans-Jakob Steiger; Joachim Windolf; Maxine Dibué-Adjei
Journal:  Epilepsy Behav Case Rep       Date:  2017-12-24
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.